Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-Child-Transmission of HIV in Tanzania

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ziske, Judith ^a   Kunz, Andrea ^a   Sewangi, Julius ^b   Lau, Inga ^a   Dugange, Festo ^c   Hauser, Andrea ^a   Kirschner, Wolf ^d   Harms, Gundel ^a   Theuring, Stefanie ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^c Kyela District Hospital   (Tanzania)

^d Forschung Beratung + Evaluation Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; BLOOD TOXICITY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GRANULOCYTOPENIA; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; SIDE EFFECT; TANZANIA; THROMBOCYTE COUNT; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BLOOD CELL COUNT; DRUG THERAPY, COMBINATION; FEMALE; HEMATOCRIT; HEMATOLOGIC DISEASES; HEMATOLOGIC TESTS; HEMOGLOBINS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; TANZANIA; YOUNG ADULT; ZIDOVUDINE;

EID: 84873529325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055633     Document Type: Article

References (28)

1. Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, et al. (2007) International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol 197: S42-55.
2. Mofenson LM, (2010) Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 50Suppl 3: S130-148.
3. World Health Organization (2011) Global HIV/AIDS Response. Epidemic update and health sector progress towards Universal Access. Progress Report 2011. Available: http://www.who.int/hiv/pub/progress_report2011/summary_en.pdf. Accessed 2013 Jan 8.
4. Eshleman SH, Guay LA, Mwatha A, Brown E, Musoke P, et al. (2005) Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012. J Acquir Immune Defic Syndr 39: 593-597.
5. McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, et al. (2009) Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 6: e1000172.
6. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, et al. (2005) Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19: 309-318.
7. Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, et al. (2010) Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One 6: e21020.
8. Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, et al. (2007) Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials 2: e11.
9. Sinha G, Choi TJ, Nayak U, Gupta A, Nair S, et al. (2007) Clinically significant anemia in HIV-infected pregnant women in India is not a major barrier to zidovudine use for prevention of maternal-to-child transmission. J Acquir Immune Defic Syndr 45: 210-217.
10. Feiterna-Sperling C, Weizsaecker K, Buhrer C, Casteleyn S, Loui A, et al. (2007) Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr 45: 43-51.
11. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S, (2003) Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17: 2053-2061.
12. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173-1180.
13. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, et al. (2006) Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis 194: 1089-1097.
14. Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, et al. (1998) Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 12: 1805-1813.
15. United Nations Development Programme (2011) Human Development Report 2011. Sustainability and Equity: A Better Future for All. Available: http://hdr.undp.org/en/media/HDR_2011_EN_Complete.pdf. Accessed 2013 Jan 8.
16. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance (2008) United Republic of Tanzania: Epidemiological Fact Sheet on HIV and AIDS. Available: http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_TZ.pdf. Accessed 2013 Jan 8.
17. Tanzania Commission for AIDS (TACAIDS), National Bureau of Statistics (NBS) (2008) Tanzania HIV/AIDS and Malaria Indicator Survey 2007-08. Available: http://www.tacaids.go.tz/dmdocuments/THMIS%202007-08.pdf. Accessed 2013 Jan 8.
18. National Institute for Allergy and Infectious Disease (NIAID), Division of AIDS (2009) Table for grading the severity of adult and pediatric adverse events, version 1.0 (2004), Clarification August 2009. Available: http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf. Accessed 2013 Jan 8.
19. Alioum A, Dabis F, Dequae-Merchadou L, Haverkamp G, Hudgens M, et al. (2001) Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med 20: 3539-3556.
20. Alioum A, Cortina-Borja M, Dabis F, Dequae-Merchadou L, Haverkamp G, et al. (2003) Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods. Am J Epidemiol 158: 596-605.
21. Sill PR, Lind T, Walker W, (1985) Platelet values during normal pregnancy. Br J Obstet Gynaecol 92: 480-483.
22. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (2011) Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal health and Interventions to Reduce Perinatal HIV Transmission in the United States. 1-207. Available: http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf. Accessed 2013 Jan 8.
23. Shah MM, Li Y, Christensen RD, (1996) Effects of perinatal zidovudine on hematopoiesis: a comparison of effects on progenitors from human fetuses versus mothers. AIDS 10: 1239-1247.
24. Briand N, Le Coeur S, Jourdain G, Hotrawarikarn S, Sirinontakan S, et al. (2010) Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand. AIDS Res Hum Retroviruses 26: 1163-1166.
25. Leroy V, Karon JM, Alioum A, Ekpini ER, Meda N, et al. (2002) Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 16: 631-641.
26. Manzi M, Zachariah R, Teck R, Buhendwa L, Kazima J, et al. (2005) High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 10: 1242-1250.
27. Mirkuzie AH, Hinderaker SG, Sisay MM, Moland KM, Morkve O, (2011) Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study. J Int AIDS Soc 14: 50.
28. Ahoua L, Ayikoru H, Gnauck K, Odaru G, Odar E, et al. (2010) Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda. J Trop Pediatr 56: 43-52.